首页 | 本学科首页   官方微博 | 高级检索  
检索        

慢性乙型肝炎治疗临床研究
引用本文:董胜利.慢性乙型肝炎治疗临床研究[J].医疗保健器具,2010,17(9):68-69.
作者姓名:董胜利
作者单位:河南省洛阳市第三人民医院,消化内科,河南,洛阳,471000
摘    要:目的探讨慢性乙型肝炎的治疗方法。方法选择60例慢性乙型肝炎患者,其中以拉米夫定抗病毒治疗30例,普通保肝治疗30例,观察时间为48周。评估包括临床症状和体征、肝功能和HBV复制指标。结果拉米夫定治疗组与普通保肝治疗组比较,疗效有显著性差异(P〈0.01)。结论拉米夫定可抑制乙肝病毒的复制,明显改善肝功能,使用安全。

关 键 词:拉米夫定  乙型肝炎病毒  慢性乙型肝炎

Clinical Study of Treatment in Chronic Hepatitis B
DONG Shengli.Clinical Study of Treatment in Chronic Hepatitis B[J].Medicine Healthcare Apparatus,2010,17(9):68-69.
Authors:DONG Shengli
Institution:DONG Shengli(Department of Gastroenterology,Luoyang Third People's Hospital,Luoyang 471000,China)
Abstract:Objective To investigate the treatment methods in chronic hepatitis B.Methods Among 60 cases of chronic hepatitis B patients,30 cases of patients were treatd with Lamivudine,and 30 cases of patients were treated with common liver-protective medicine.The surveying time was 48 weeks.Assessment included clinical symptoms and signs,liver function and indicators of HBV replication.Result There was significant difference in efficacy between Lamivudine group and the common liver-protective group(P 0.01).Conclusion The Lamivudine can suppress HBV replication,with a significant improvement in hepatic function and a safty use.
Keywords:Lamivudine  Hepatitis B virus  Chronic Hepatitis B
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号